Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2022
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GISarah Jane Schwarzenberg, Phuong T Vu, Michelle Skalland, et al.
The Lancet. Respiratory Medicine|November 7, 2022
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Felix Ratjen, Renee Russell, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2021
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical TrialDavid P Nichols, Alex C Paynter, Sonya L Heltshe, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis BronchiectasisKathryn A Ramsey, Alice C H Chen, Giorgia Radicioni, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 24, 2018
CFTR modulator theratyping: Current status, gaps and future directionsJohn Paul Clancy, Calvin U Cotton, Scott H Donaldson, et al.
The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Pageof 7